华熙生物
(688363)
| 流通市值：159.72亿 | | | 总市值：159.72亿 |
| 流通股本：4.82亿 | | | 总股本：4.82亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,596,018,408.81 | 1,756,179,663.09 | 829,407,051.84 | 4,199,089,274.55 |
| 营业总成本 | 2,451,826,898.24 | 1,637,063,792.57 | 752,718,280.03 | 3,825,862,023.08 |
| 其他经营收益 | | | | |
| 营业利润 | 191,113,511.98 | 154,430,569.43 | 70,898,159.16 | 333,092,312.52 |
| 利润总额 | 189,541,442.74 | 152,082,352.15 | 68,019,672.45 | 333,802,004.82 |
| 净利润 | 186,257,951.59 | 153,164,597.52 | 65,004,705.35 | 291,148,370.39 |
| 每股收益 | | | | |
| 其他综合收益 | -74,758,854.7 | -57,284,446 | -20,527,812.3 | 38,976,111.47 |
| 综合收益总额 | 111,499,096.89 | 95,880,151.52 | 44,476,893.05 | 330,124,481.86 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,738,544,185.87 | 2,848,325,471.74 | 2,861,528,714.58 | 2,784,992,938.78 |
| 非流动资产: | | | | |
| 非流动资产合计 | 6,014,029,636.98 | 6,032,658,110.42 | 5,888,477,275.25 | 5,907,514,385.78 |
| 资产总计 | 8,752,573,822.85 | 8,880,983,582.16 | 8,750,005,989.83 | 8,692,507,324.56 |
| 流动负债: | | | | |
| 流动负债合计 | 1,160,485,995.43 | 1,328,042,894.53 | 1,211,345,560.34 | 1,190,006,546.26 |
| 非流动负债: | | | | |
| 非流动负债合计 | 450,450,624.9 | 428,602,430.48 | 379,036,517.05 | 387,353,758.91 |
| 负债合计 | 1,610,936,620.33 | 1,756,645,325.01 | 1,590,382,077.39 | 1,577,360,305.17 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 7,106,096,764.81 | 7,090,270,154.64 | 7,129,780,906.49 | 7,085,653,979.19 |
| 股东权益合计 | 7,141,637,202.52 | 7,124,338,257.15 | 7,159,623,912.44 | 7,115,147,019.39 |
| 负债和股东权益合计 | 8,752,573,822.85 | 8,880,983,582.16 | 8,750,005,989.83 | 8,692,507,324.56 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,144,568,012.85 | 2,176,974,803.19 | 946,110,823.34 | 4,700,452,538.27 |
| 经营活动现金流出小计 | 2,565,169,065.61 | 1,652,800,846.42 | 815,150,812.66 | 4,073,002,605.95 |
| 经营活动产生的现金流量净额 | 579,398,947.24 | 524,173,956.77 | 130,960,010.68 | 627,449,932.32 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 783,985,248.96 | 524,678,978.18 | 417,466,228.34 | 463,625,517.03 |
| 投资活动现金流出小计 | 1,346,458,544.12 | 1,098,300,993.22 | 561,478,184.12 | 728,491,200.09 |
| 投资活动产生的现金流量净额 | -562,473,295.16 | -573,622,015.04 | -144,011,955.78 | -264,865,683.06 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 152,937,166.66 | 71,257,166.66 | 66,665,000 | 312,800,683.61 |
| 筹资活动现金流出小计 | 315,841,511.34 | 154,714,661.7 | 32,019,440.61 | 315,100,080.3 |
| 筹资活动产生的现金流量净额 | -162,904,344.68 | -83,457,495.04 | 34,645,559.39 | -2,299,396.69 |
| 汇率变动对现金及现金等价物的影响 | -22,679,495.29 | -16,719,149.77 | -8,475,867.36 | 3,998,656.12 |
| 现金及现金等价物净增加额 | -168,658,187.89 | -149,624,703.08 | 13,117,746.93 | 364,283,508.69 |
| 期末现金及现金等价物余额 | 809,117,729.17 | 828,151,213.98 | 990,893,663.99 | 977,775,917.06 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -149,624,703.08 | - | 364,283,508.69 |
最新报告期：2026-11-10| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华创证券 | 汤秀洁 | 0.61 | 0.74 | 0.85 | 2026-11-10 |
| 中泰证券 | 郑澄怀 | 0.65 | 0.85 | 1.01 | 2026-11-03 |
| 申万宏源 | 王盼,聂霜,王立平 | 0.63 | 0.82 | 1.01 | 2026-11-02 |
| 广发证券 | 嵇文欣 | 0.73 | 0.91 | 1.10 | 2026-10-30 |
| 方正证券 | 周昕,谷寒婷 | 0.53 | 0.76 | 0.95 | 2026-10-30 |